Hyperparathyroidism in a Fracture Population

Area of Science:

• Endocrinology
• Bone Metabolism
• Skeletal Health

Background:

• Primary hyperparathyroidism (PHPT) is a common endocrine disorder characterized by excess parathyroid hormone (PTH) and hypercalcemia.
• PHPT, often asymptomatic, can lead to osteoporosis and fractures, primarily affecting cortical bone.
• Normocalcemic hyperparathyroidism (NPHPT) presents with normal calcium but elevated PTH, with emerging evidence linking it to osteoporotic fractures.

Purpose of the Study:

• To summarize the clinical presentation, diagnosis, and treatment of PHPT.
• To review the skeletal implications of PHPT and NPHPT.
• To highlight the significance of hyperparathyroidism in fracture patients.

Main Methods:

• Review of clinical presentation and biochemical/hormonal assessment for PHPT diagnosis.
• Discussion of diagnostic imaging (ultrasound, 99mTc-sestamibi scintigraphy) for surgical guidance.
• Analysis of existing literature on NPHPT and its skeletal effects.

Main Results:

• PHPT diagnosis relies on clinical and biochemical evaluation.
• Surgical intervention, guided by imaging, is typically curative for PHPT.
• NPHPT is associated with an increased risk of osteoporotic fractures.

Conclusions:

• Hyperparathyroidism, in its various forms, contributes significantly to the fracture burden in patients.
• Fracture liaison services encounter a notable proportion of patients with hyperparathyroidism-related skeletal issues.
• Further research into NPHPT's skeletal impact is warranted.